KRYS (KRYS)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 7/9, Altman Z 39.5 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency of KRYS demonstrates a robust economic moat, evidenced by an ROIC-WACC spread of +2.3%, indicating value creation that exceeds the cost of capital. This profitability is primarily driven by exceptional operational leverage rather than financial engineering or margin compression; the DuPont decomposition reveals a gross margin of 94.1% and net margin of 52.6%, suggesting pricing power dominates earnings generation while turnover remains implicit in the high spread. Creditworthiness metrics further reinforce this fundamental quality, with an Altman Z-Score of 39.5 signaling negligible bankruptcy risk and a Beneish M-Score of -2.28 indicating low probability of financial manipulation. The Piotroski F-Score of 7/9 corroborates strong balance sheet health and positive operating trends, painting a picture of a financially resilient entity with high-quality earnings supported by significant revenue growth of 33.9% year-over-year.
Valuation metrics present a mixed signal regarding current pricing relative to intrinsic value and historical norms. The stock trades at a P/E multiple of 36.0x, which requires scrutiny against sector averages and the company's own historical range to determine if this premium is justified by its growth trajectory or represents overextension given the +2.3% spread on capital returns. Conversely, the DCF model implies a fair value of $343 per share; comparing this intrinsic target directly with current market prices reveals whether the equity is trading at a discount or premium to its calculated present value based on expected cash flows and implied growth rates. The divergence between the high multiple and specific valuation models suggests investors are pricing in aggressive future performance, though the magnitude of that expectation relative to the 36x earnings yield warrants careful assessment against the underlying capital efficiency metrics previously noted.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6% | 8% | 10% |
|---|---|---|---|
| 2% | $445 | $295 | $221 |
| 3% | $573 | $343 | $245 |
| 4% | $828 | $415 | $276 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=8.0%, terminal growth 3%. Fair value $343 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XBI or SLYG, the fund manager is mechanically forced to buy or sell KRYS shares regardless of KRYS's individual fundamentals. We estimate $554M of passive capital is structurally linked to KRYS through 8 tracked ETFs. Passive flows have a limited but growing influence on KRYS's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in KRYS to visualize passive redemption contagion across ETFs and collateral stocks.
If KRYS (KRYS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ALKERMES PLC (ALKS) as the most exposed collateral stock, sharing 3 ETFs with KRYS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 10 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
KRYS Ownership Dynamics
ETFs with Highest KRYS Exposure
Float lock-up computed from 10 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
KRYS Capital Efficiency
How efficiently does KRYS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
KRYS converts 113% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 2.3% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-04-21 | 6,493 | $276.50 | $1.8M |
| 2026-04-14 | 26 | $267.41 | $6,952.66 |
| 2026-03-10 | 11 | $258.65 | $2,845.15 |
| 2026-03-09 | 2,097 | $253.69 | $531,987.93 |
| 2026-02-27 | 611 | $276.36 | $168,855.96 |
| 2026-02-23 | 41 | $261.80 | $10,733.8 |
| 2026-02-19 | 24,545 | $283.29 | $7.0M |
| 2026-02-17 | 273 | $276.45 | $75,470.85 |
| 2026-02-12 | 6 | $272.65 | $1,635.9 |
| 2026-02-10 | 725 | $272.61 | $197,642.25 |
| 2026-02-09 | 2,032 | $272.74 | $554,207.68 |
| 2026-01-30 | 1,844 | $279.34 | $515,102.96 |
| 2026-01-26 | 8,529 | $281.53 | $2.4M |
| 2026-01-20 | 3,489 | $285.04 | $994,504.56 |
| 2026-01-14 | 66 | $291.93 | $19,267.38 |
| 2026-01-13 | 56 | $272.13 | $15,239.28 |
| 2026-01-07 | 768 | $249.39 | $191,531.52 |
| 2026-01-02 | 1,135 | $246.54 | $279,822.9 |
| 2025-12-22 | 13,464 | $240.80 | $3.2M |
| 2025-12-11 | 629 | $239.72 | $150,783.88 |
| 2025-12-10 | 5,281 | $234.64 | $1.2M |
| 2025-12-09 | 1,201 | $234.05 | $281,094.05 |
| 2025-11-26 | 2 | $216.97 | $433.94 |
| 2025-11-24 | 1 | $212.02 | $212.02 |
| 2025-11-20 | 440 | $204.10 | $89,804 |
| 2025-11-17 | 1,450 | $206.16 | $298,932 |
| 2025-11-14 | 36 | $201.21 | $7,243.56 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare KRYS to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.